 BOSTON--BUSINESS WIRE--Myomo, Inc. NYSE American: MYO Myomo or the Company, a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Thomas Jefferson University of Philadelphia has successfully completed the first phase of clinical trials using sensors imbedded in the brain to control a MyoPro powered brace worn by a stroke patient. The story is detailed in the University web 